SugarMD Super Berberine (DHB and Ceylon Cinnamon) 30 Capsules - NEW Formula

• Advanced Dual-Ingredient Formula: Uniquely combines Dihydroberberine (DHB) and 100% Pure Ceylon Cinnamon for a synergistic approach to metabolic wellness.

• 5X Greater Bioavailability: Features Dihydroberberine (DHB), which offers five times greater bioavailability than standard berberine for more effective and longer-lasting benefits.

• Comprehensive Metabolic Support: This formula is designed to deliver superior support for:

• Healthy glucose metabolism and balanced blood sugar levels¹ ².

• Healthy weight management efforts.

• Cellular health and reduced inflammation³.

• Enhanced overall metabolic function.

• Safer, Superior Cinnamon: Uses only Ceylon Cinnamon, a pure and safe alternative to common cassia cinnamon, making it ideal for daily use without concerns about coumarin.

• Commitment to Purity & Quality: Every batch is "Lab Tested for Purity" to ensure it is free from contaminants like pesticides and heavy metals. We are committed to clean, natural ingredients crafted to the highest wellness standards.

Important Disclaimer:

• This product is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease.

• These statements have not been evaluated by the Food and Drug Administration (FDA).

• Consult your healthcare provider before use, especially if you are pregnant, nursing, taking medications, or have a medical condition. Not intended for individuals under 18.

• Gallery images are for reference only. Actual product details may vary.
  

References:

1. Moon, Jessica M., Kayla M. Ratliff, Anthony M. Hagele, Richard A. Stecker, Petey W. Mumford, and Chad M. Kerksick. 2022. "Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial" Nutrients 14, no. 1: 124. 
2. Ranasinghe, P., Galappaththy, P., G.R. Constantine, et al. "Cinnamomum zeylanicum (Ceylon Cinnamon) as a Potential Pharmaceutical Agent for Type-2 Diabetes Mellitus: Study Protocol for a Randomized Controlled Trial." Trials 18 (2017): 446.
3. Ranasinghe, P., Galappaththy, P., G.R. Constantine, et al. "Cinnamomum zeylanicum (Ceylon Cinnamon) as a Potential Pharmaceutical Agent for Type-2 Diabetes Mellitus: Study Protocol for a Randomized Controlled Trial." Trials 18 (2017): 446.